Aptose Biosciences Inc
0.0547 (10.28%)
Stock Name Stock Symbol Market Stock Type
Aptose Biosciences Inc APTO NASDAQ Common Stock
  Price Change Price Change % Stock Price Last Trade
0.0547 10.28% 0.5867 08:57:12
Open Price Low Price High Price Close Price Previous Close
0.5201 0.5201 0.599 0.5867 0.532
more quote information »

Recent News

Date Time Source Heading
13/3/202321:05EDGARCurrent Report Filing (8-k)
15/2/202309:19EDGARAmended Statement of Ownership (sc 13g/a)
30/1/202323:06EDGARCurrent Report Filing (8-k)
17/1/202322:08EDGARStatement of Ownership (sc 13g)
07/1/202300:50EDGARCurrent Report Filing (8-k)
13/12/202203:55TRMNJonesTrading Keeps Their Buy Rating on Aptose Biosciences..
13/12/202200:01EDGARCurrent Report Filing (8-k)
12/12/202222:01EDGARCurrent Report Filing (8-k)
12/12/202222:01EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
08/12/202208:15EDGARCurrent Report Filing (8-k)
18/11/202201:55TRMNAptose Biosciences (APTO) Gets a Buy from H.C. Wainwright
04/11/202200:11EDGARCurrent Report Filing (8-k)
02/11/202222:45TRMNJonesTrading Remains a Buy on Aptose Biosciences (APTO)
02/11/202221:15TRMNH.C. Wainwright Reaffirms Their Buy Rating on Aptose..
02/11/202207:17EDGARQuarterly Report (10-q)
02/11/202207:02EDGARCurrent Report Filing (8-k)
24/10/202221:05EDGARNotice of Effectiveness (effect)
22/10/202208:15EDGARProspectus Filed Pursuant to Rule 424(b)(2) (424b2)
11/10/202221:01EDGARSecurities Registration Statement (simplified Form) (s-3)
22/9/202208:08EDGARStatement of Changes in Beneficial Ownership (4)
22/9/202208:07EDGARStatement of Changes in Beneficial Ownership (4)
13/9/202222:45EDGARCurrent Report Filing (8-k)
12/9/202221:35EDGARCurrent Report Filing (8-k)
03/8/202222:22TRMNJonesTrading Thinks Aptose Biosciences’ Stock is Going to..
03/8/202221:21TRMNCanaccord Genuity Thinks Aptose Biosciences’ Stock is Going..
03/8/202220:26TRMNH.C. Wainwright Thinks Aptose Biosciences’ Stock is Going to..
03/8/202207:03EDGARQuarterly Report (10-q)
03/8/202206:11EDGARCurrent Report Filing (8-k)
22/7/202221:31EDGARCurrent Report Filing (8-k)
20/7/202220:01EDGARCurrent Report Filing (8-k)
08/7/202208:39EDGARStatement of Changes in Beneficial Ownership (4)
29/6/202206:17EDGARStatement of Changes in Beneficial Ownership (4)
29/6/202206:13EDGARInitial Statement of Beneficial Ownership (3)
29/6/202205:31EDGARCurrent Report Filing (8-k)
27/6/202223:56EDGARCurrent Report Filing (8-k)
07/6/202206:52EDGARAmended Current Report Filing (8-k/a)
07/6/202206:14EDGARStatement of Changes in Beneficial Ownership (4)
03/6/202222:25TRMNJonesTrading Thinks Aptose Biosciences’ Stock is Going to..
03/6/202207:30EDGARCurrent Report Filing (8-k)
01/6/202207:14EDGARCurrent Report Filing (8-k)
11/5/202202:55TRMNAlliance Global Partners Thinks Aptose Biosciences’ Stock is..
10/5/202223:40TRMNAnalysts Offer Insights on Healthcare Companies: Aptose..
10/5/202220:23TRMNAptose Biosciences (APTO) Gets a Buy Rating from H.C...
10/5/202207:02EDGARQuarterly Report (10-q)
10/5/202206:38EDGARCurrent Report Filing (8-k)
04/5/202221:40EDGARCurrent Report Filing (8-k)
03/5/202207:07EDGARCurrent Report Filing (8-k)
20/4/202220:05EDGARProxy Statement (definitive) (def 14a)
12/4/202207:05EDGARCurrent Report Filing (8-k)
02/4/202207:53EDGARPost-effective Amendment to an S-8 Filing (s-8 Pos)
Your Recent History
Aptose Bio..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20230321 02:24:47